Transcript: David Beasley on "Face the Nation"
The following is a transcript of an interview with David Beasley, Executive Director for the UN World Food Programme, that aired Sunday, November 29, 2020, on "Face the Nation."
Vaccine
Transcript: Deborah Birx on "Face the Nation"
The following is a transcript of an interview with White House Coronavirus Response Coordinator Dr. Deborah Birx that aired Sunday, November 29, 2020, on "Face the Nation."
Looking at what's next with COVID-19
What's next with COVID-19? CBS News medical contributor Dr. David Agus takes a look at the surge of cases, the impact of the holidays and the latest with vaccines.
What is a coronavirus testing desert?
CBS News correspondent Mark Strassmann spoke with Jennifer Nuzzo, a senior scholar at the Johns Hopkins Center for Health Security, about areas where people don't have access to coronavirus tests, known as testing deserts.
Nasdaq, S&P 500 notch new highs as investors bank on vaccine
Hope that pandemic can be halted propels Wall Street to its third weekly gain in the past four weeks.
Doctor warns of false sense of COVID security
Millions stuck with their Thanksgiving plans despite a warning from the Centers for Disease Control and Prevention for travelers to just stay home because of the coronavirus pandemic. More than 2,200 COVID-related deaths were reported in the U.S. on the day before Thanksgiving, the highest one-day toll in more than six months. CBS News correspondent Adriana Diaz reports from Chicago, and Dr. Shoshana Ungerleider, an internal medicine physician at California Pacific Medical Center, joined CBSN to discuss.
Expert sees "nothing sinister" amid questions over vaccine's data
AstraZeneca and Oxford University acknowledged a manufacturing error that raised questions about preliminary results of their experimental COVID-19 vaccine.
U.S. marks deadliest day in months
The U.S. reported the deadliest day in the coronavirus pandemic since early May with more than 2,200 deaths. CBS News medical contributor Dr. David Agus joins "CBS This Morning" to discuss Thanksgiving concerns as millions of Americans travel for the holiday. He also comments on the AstraZeneca-Oxford coronavirus vaccine candidate.
CDC weighs shortening COVID-19 quarantine period
As coronavirus cases in the U.S. spike to record highs, the Centers for Disease Control and Prevention are considering a change to the agency's recommendation about quarantining for 14 days after a person tests positive for coronavirus. Dr. Wilbur Chen-- a professor at the University of Maryland School of Medicine, the director of the UMB Travel Medicine Practice and the chief of adult clinical studies at the Center for Vaccine Development and Global Health -- joins CBSN to discuss the latest developments for a possible coronavirus vaccine and the CDC's approach to vaccine guidelines.
Vaccine czar on distribution timeline
Even as the number of U.S. COVID-19 cases surpasses 12.5 million, there is some positive news. AstraZeneca is now the third pharmaceutical company with a promising vaccine candidate. Moncef Slaoui leads the U.S. vaccine development for Operation Warp Speed and he joins "CBS This Morning" to discuss how the federal government is preparing for a vaccine rollout.
Health secretary says vaccine distribution could begin within weeks
Health secretary said the White House task force is now in communication with Mr. Biden's transition team.
Hospitalizations at all-time high
Millions of people are traveling for Thanksgiving as coronavirus hospitalizations reach an all-time high. Dr. Uché Blackstock, a medical contributor for Yahoo News, joined CBSN to discuss the danger of holiday travel and other updates on the pandemic.
Childhood vaccination rates have dropped during the pandemic
"Let your guard drop and measles will come raging back." Dr. Paul Offit said.
Arline CEO: Vaccine will be "necessity" for international travel
The airline's CEO said vaccines will be a "necessity" for travelers flying international.
Miami hospital preparing for COVID-19 vaccine distribution
CBS News was granted rare access into Jackson Memorial Hospital's COVID-19 ward and the extremely cold freezer where the coronavirus vaccine will be stored.
Doctor explains effectiveness of COVID vaccine
AstraZeneca announced Monday that its COVID-19 vaccine is up to 90% effective and even shows signs of reducing asymptomatic spread. It's effectiveness varied during clinical trials, depending on the dosage, but still averaged 70%. Dr. Uzma Syed, an infection disease specialist at New York's Good Samaritan Hospital Medical Center and director of Antimicrobial Stewardship Center of Excellence, joins CBSN's Elaine Quijano to discuss if the variation in effectiveness is something people should be concerned about.
AstraZeneca COVID-19 vaccine up to 90% effective
The coronavirus vaccine being developed by AstraZeneca and the University of Oxford is up to 90% effective in preventing the disease, with clinical trials also showing that it may stop transmission among people. Charlie D'Agata continues our series "Racing to a Cure."
AstraZeneca-Oxford COVID vaccine up to 90% effective, trials show
Three drugmakers have now reported similarly hopeful results in two weeks. U.K. Prime Minister calls the news from AstraZeneca and Oxford University "incredibly exciting."
Concerns over vaccine plans for nursing homes
CBS MoneyWatch senior reporter Stephen Gandel joins CBSN to discuss the wide range of concerns geriatric specialists are citing in the government's plan to vaccinate over a million Americans who live in nursing homes.
Oxford COVID vaccine shows promising results
Another potential coronavirus vaccine is showing promising results. Charlie D'Agata reports from Oxford University in England on the AstraZeneca vaccine trial.
AstraZeneca vaccine up to 90% effective
The AstraZeneca vaccine created with Oxford University is another sign of hope for the world as cases and hospitalizations run rampant. Dr. Amesh Adalja joins CBSN to discuss both the vaccine and an antibody treatment approved by the FDA.
COVID-19 cases climbing ahead of Thanksgiving
The Thanksgiving travel rush is underway as coronavirus infections are skyrocketing across the country. CBS News' Bofta Yimam joins CBSN AM with more.
ER doctor on COVID vaccine process
With one week left in November, the U.S. has already seen its highest monthly coronavirus case total. This comes as AstraZeneca announced that trials show its vaccine is up to 90% effective. CBS News' Charlie D'Agata reports on the findings, and Dr. Ron Elfenbein, medical director and owner of FirstCall Medical Center, joined CBSN to break down what we know so far about the vaccine options. He also explains why a new antibody drug approved by the FDA may be limited in the scope of who it can help.
Dr. Jha on COVID-19 vaccine developments
The U.S. has reported more than 12 million cases of coronavirus as of Sunday and nationwide hospitalizations are at a record high. Dr. Ashish Jha, dean of Brown University's School of Public Health, joins "CBS This Morning" to discuss the latest news on COVID-19 vaccines, the surge in cases and the potential impact of people traveling over Thanksgiving.
Experts warn against traveling this Thanksgiving amid pandemic
Dr. Jon LaPook discusses the risks of gathering and traveling for Thanksgiving as the amount of coronavirus cases sees no end.
3 children, 1 teacher killed in Oregon school shooting, police say
Vance says "selling access to the White House" is "disgusting"
White House prepares plans to use "mother of all bombs" on Iran
Exclusive
Ousted general warned of missile defense shortage before Iran war
Live
Strait of Hormuz still unsafe for ships, maritime group warns
Trump calls off plan to livestream Fort Hood shooter's execution
White House's Katie Zacharia confirms she never passed bar exam
Sikh separatist says FBI warned him of new threat against him
